| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a13479c58c71914f95114497b301ea75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32c8074617958fd27763c00e2cd0f29a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c122eb351b62eef8c0a1ce9090f84d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa483f86cc4003166ba4a17f7117bc12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18908b0cea0b414ca6e332fe9ed7ad96 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1300ece2af8de06dc428434279d566e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a0678a1f88db48768f9d47c80a53a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9535796842d85b8a5c895845c259a227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_211ca4d62fa59a88c3cb3297011e5627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f20f0bb1f4989e798ed559154b27b87b |
| publicationDate |
2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008213385-A1 |
| titleOfInvention |
Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin |
| abstract |
The present invention relates to nanoparticulate compositions in which the active agent is a topoisomerase I inhibitor and pharmaceutical compositions comprising the nanoparticulate compositions that are useful for the treatment and prevention of proliferative diseases including cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014294973-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140057384-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10391056-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013067449-A1 |
| priorityDate |
2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |